Clinical Trial Update: Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer [Phase 2]

View source ↗

Summary

This clinical trial update reports the results of a Phase 2 study evaluating capecitabine, oxaliplatin, and bevacizumab with radiation therapy in biliary tract …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Gallbladder Adenocarcinoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Biliary Tract Cancer, Gallbladder Adenocarcinoma | Phase 2 | Status: COMPLETED